Gujarat Themis Biosyn Ltd. operates as a pharmaceutical company. The firm engages in the manufacture of drugs. Its products include Rifamycin and Lovastatin. The company was founded on December 11, 1981 and is headquartered in Mumbai, India.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GUJTHEM is 311.95 INR — it has decreased by −1.89% in the past 24 hours. Watch GUJARAT THEMIS BIOSYN LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange GUJARAT THEMIS BIOSYN LTD. stocks are traded under the ticker GUJTHEM.
GUJTHEM stock has risen by 5.07% compared to the previous week, the month change is a 6.47% rise, over the last year GUJARAT THEMIS BIOSYN LTD. has showed a 149.23% increase.
GUJTHEM reached its all-time high on Sep 25, 2024 with the price of 390.00 INR, and its all-time low was 0.60 INR and was reached on Mar 4, 2009. View more price dynamics on GUJTHEM chart. See other stocks reaching their highest and lowest prices.
GUJTHEM stock is 4.77% volatile and has beta coefficient of 1.43. Track GUJARAT THEMIS BIOSYN LTD. stock price on the chart and check out the list of the most volatile stocks — is GUJARAT THEMIS BIOSYN LTD. there?
Today GUJARAT THEMIS BIOSYN LTD. has the market capitalization of 33.99 B, it has increased by 4.31% over the last week.
GUJTHEM net income for the last quarter is 105.66 M INR, while the quarter before that showed 132.36 M INR of net income which accounts for −20.17% change. Track more GUJARAT THEMIS BIOSYN LTD. financial stats to get the full picture.
GUJARAT THEMIS BIOSYN LTD. dividend yield was 0.25% in 2023, and payout ratio reached 12.28%. The year before the numbers were 0.79% and 67.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 265.00 employees. See our rating of the largest employees — is GUJARAT THEMIS BIOSYN LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GUJARAT THEMIS BIOSYN LTD. EBITDA is 726.15 M INR, and current EBITDA margin is 46.38%. See more stats in GUJARAT THEMIS BIOSYN LTD. financial statements.
Like other stocks, GUJTHEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUJARAT THEMIS BIOSYN LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GUJARAT THEMIS BIOSYN LTD. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GUJARAT THEMIS BIOSYN LTD. stock shows the buy signal. See more of GUJARAT THEMIS BIOSYN LTD. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.